or perhaps because of it — there seem to be an inordinately high number of aspiring futurists out there. Industry pundits breathlessly trot out the latest trend for such concepts as shopper marketing, digital marketing, loyalty card analytics, big data and
It’s been said that if you don’t know where you are going, any road will take you there. Change the word “road” to “aisle” and you have the retail world’s equivalent of the familiar adage.
These are stunning times for chain drug retailing in America. Events are tumbling willy-nilly one atop another, with the result that the nature of the entire industry is changing as dramatically and quickly as it has ever changed. More significantly, it will never again be what it once was.
Implementation of the major provisions of the Patient Protection and Affordable Care Act (ACA) occurs less than nine months from now.
he resigned late last month to accept a job as chief executive officer of RadioShack —was certainly one of the stunning developments that have periodically punctuated chain drug retailing in recent years, an event made
The changes transforming health care delivery, in both Canada and the United States, are creating openings for community pharmacy operators to expand the scope of professional practice.
Earlier this month the brightest people in chain drug store retailing gathered in Fort Lauderdale, Fla. They came to analyze the state of their businesses and, more specifically, the direction of chain drug retailing in America.
both directional and financial — translate into challenges and opportunities for chain pharmacy. Following the most recent November elections, our country has retained the same set of political players to address many of the same fiscal issues that continue to perplex the nation’s government. As a
Much has been made of the competition between CVS and Walgreens for supremacy in chain drug retailing and leadership in the health care community. And indeed there is little doubt that these two health care retailers are in a class by themselves when it comes to providing patient care.
and the impact they may begin to exert in 2013. • The Walgreens-Alliance Boots alliance. Walgreens’
No one can accuse Bob Miller of being afraid of a challenge. During a long and distinguished career in mass market retailing the chief executive officer of Albertson’s LLC has proven equal to any assignment that he has taken on, including at least one where few people thought anybody could succeed.
By the close of 2012 two key questions regarding the Affordable Care Act were finally addressed: one, whether the health care reform law is constitutional and, two, whether it would be repealed under a new administration.
No more confusing or misunderstood retail or health care alliance exists today than the relationship among the CVS drug chain, the Caremark PBM and the MinuteClinic immediate-care network.
As the new year begins, retail pharmacy operators are confronted with a host of pressing issues that will affect the measure of success they can achieve as health care providers and business enterprises.
It’s human nature to look ahead to the New Year. What will 2013 hold for America’s biopharmaceutical research sector? Well, quite a bit. John Castellani We will join other stakeholders in the dialogue over the role of health care costs in our nation’s economic challenges.
If you’re within a thousand miles of Chicago, make the journey to the Windy City and drop in on the new, 30,000-square-foot (25,000-square-foot selling) Walgreens drug store in the city’s Bucktown/Wicker Park neighborhood.
